Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol-Reference-Cited by-同舟云学术

Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol

Published:2020-05 Issue: Volume:21 Page:201-204
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Di Giuseppe Luis A.,Buela Gabriela,Zacariaz Hereter Johana B.,Terrasa Sergio A.,Garfi Leonardo G.,Soriano Enrique R.

Funder

Universidad Nacional del Centro de la Provincia de Buenos Aires

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference27 articles.

1. Health Care and Research Essential Medicines and Biological Products Project (THR/EM). Access to high-cost medicines in the Americas: context, challenges and perspectives,2009

2. Application of risk-sharing contracts to finance new medicines;Puig-Junoy;Sanit Clin Manag,2004

3. No cure, no pay;Møldrup;BMJ,2005

4. Innovative schemes to improve market access for new technologies: risk-sharing agreements;Espina;Gac Sanit,2010

5. Setting up an outcomes guarantee for pharmaceuticals: new approach to risk sharing in primary care;Chapman;BMJ,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and Threats of the Legally Facilitated Performance-Based Managed Entry Agreements in Slovakia: The Early-Adoption Perspective;Healthcare;2023-04-19

2. Experiencia de un contrato de riesgo compartido basado en resultados para el tratamiento de psoriasis en placa con secukinumab (Cosentyx);Economía de la Salud;2022-07